University of Bristol


Project role
The Medical Physics Research Centre is the principal contractor, co-ordinating
the project and drawing on previous experience concerning EU projects
within the Department. It has some 19 staff within both the University
and the National Health Service (United Bristol Healthcare NHS Trust
– UBHT) and is directly linked with a large Medical Physics Department
with over 100 staff.
The
Department has already been involved in a number of EU projects (MIDSTEP,
DOLPHINS, TREMOR, FESTIVAL, CEPHOS and MARCH) proving its capacity to
contribute to EU based research. We are investigating the placental
transfer of radioactive-labelled xenobiotics in an in vitro human perfused
placenta model and the biodistribution in an alternative laboratory
model. A Berthold linear analyser and an LKB-Wallac automatic beta counter
are used for imaging and measurement of radiolabelled material.
The Team
Dr Margaret Saunders,
BSc, PhD, is a Senior Clinical Scientist and Research Associate within
the Faculty of Medicine. She has extensive experience over the last
13 years in the fields of radiation protection and immunology, with
respect to environmental radionuclide contaminants, investigation of
T cell responses to antigens and tolerance mechanisms in the mucosal
immune system. Currently Radiation Protection Supervisor within the
Department. Responsibility for training of junior staff employed on
the project and for overall management and co-ordination.
Dr Maria Palmer,
BPharm, MSc, PhD, is the Director of Research & Development for
UBHT and Principal Radiopharmacist. She has extensive experience over
the last 23 years in the areas of nuclear medicine and biodistribution
studies as well as wide management experience.
Professor Alan Preece,
BSc, PhD, is Professorial Research Fellow in Medical Physics and Consultant
Medical Physicist. He has some 26 years experience in radiation research,
encompassing biodistribution studies, cancer immunology, and impact
of environmental factors on physiological measurements and has extensive
experience in issues involving research ethics.
Collectively, the team have been involved in the study of the placental
transfer of both medical and environmentally important radionuclides
over the previous 9 years with receipt of funding from the United Kingdom
Co-ordinating Committee for cancer research (UKCCCR), National Radiological
Protection Board (NRPB) and the Department of Health. This has extended
our expertise in the biodistribution and placental transfer of radiolabelled
material including beta-emitters requiring the use of liquid scintillation
techniques and has facilitated the development of the in vitro human
perfused placenta model for the study of the transfer of radionuclides.
This expertise is highly relevant to our contribution to the project.
Other team members:
Jan Fox, Technician
Claire Salisbury, Clinical Scientist
Deirdre Chandler, Project Administrator
Top